MicroRNAs: New actors in the oral cancer scene

Oral Oncology

Volumn 47, Issue 5, 2011, Pages 314-319

  Wu, Bo Hai ^a   Xiong, Xue Peng ^a   Jia, Jun ^a   Zhang, Wen Feng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Chemoresistance; Diagnosis; Head and neck squamous cell carcinoma; Metastasis; MicroRNA; Oral squamous cell carcinoma; Prognosis; Proliferation; Therapy

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

APOPTOSIS; BODY FLUID; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER THERAPY; CELL CYCLE; CELL DIFFERENTIATION; DOWN REGULATION; HUMAN; METASTASIS; MOUTH CARCINOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOUTH NEOPLASMS; ONCOGENES; PROGNOSIS;

EID: 79956204410     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.03.019     Document Type: Review

References (62)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75(5):843-54. (Pubitemid 24014542)
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281-97.
3. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. MiRBase: tools for microRNA genomics. Nucleic Acids Res 2008;36:D154-8 (Database issue).
4. Huppi K, Volfovsky N, Mackiewicz M, Runfola T, Jones TL, Martin SE, et al. MicroRNAs and genomic instability. Semin Cancer Biol 2007;17(1):65-73. (Pubitemid 46084848)
5. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007;26(30):4442-52. (Pubitemid 47014466)
6. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008;68(7):2094-105. (Pubitemid 351521781)
7. Yu T, Wang XY, Gong RG, Li A, Yang S, Cao YT, et al. J Exp Clin Cancer Res 2009;28:64.
8. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008;14(9):2588-92.
9. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O'Brien C, et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007;358(1):12-7. (Pubitemid 46722705)
10. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, et al. MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 2008;123(12):2791-7.
11. Barker EV, Cervigne NK, Reis PP, Goswami RS, Xu W, Weinreb I, et al. Mol Cancer 2009;8:127.
12. Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009;15(8):2850-5.
13. Ramdas L, Giri U, Ashorn CL, Coombes KR, El-Naggar A, Ang KK, et al. MiRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck 2009;31(5):642-54.
14. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009;174(3):736-45.
15. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, et al. Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010;16(4):1129-39.
16. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 2009;18(24):4818-29.
17. Liu X, Jiang L, Wang A, Yu J, Shi F, Zhou X. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 2009;286(2):217-22.
18. Liu X, Yu J, Jiang L, Wang A, Shi F, Ye H, et al. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics 2009;6(3):131-9.
19. Yu ZW, Zhong LP, Ji T, Zhang P, Chen WT, Zhang CP. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. Oral Oncol 2010;46(4):317-22.
20. Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 2007;6:5.
21. Deng S, Calin GA, Croce CM, Coukos G, Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008;7(17):2643-6.
22. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 2009;35(6):856-67.
23. Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, et al. A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res 2009;69(1):65-74.
24. Han L, Witmer PD, Casey E, Valle D, Sukumar S. DNA methylation regulates microRNA expression. Cancer Biol Ther 2007;6(8):1284-8. (Pubitemid 351590384)
25. Langevin SM, Stone RA, Bunker CH, Grandis JR, Sobol RW, Taioli E. MicroRNA- 137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis 2010;31(5):864-70.
26. Wu MQ, Jolicoeur N, Li Z, Zhang LH, Fortin Y, L'Abbe D, et al. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 2008;29(9):1710-6.
27. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010;10(6):389-402.
28. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, et al. Genetic variation in microRNA genes and risk of oral premalignant lesions. Mol Carcinog 2010;49(2):183-9.
29. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM, et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010;116(20):4753-60.
30. Calin GA, Sevignani C, Dan Dumitru C, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. In: Proceedings of the national academy of sciences of the United States of America 2004;101(9):2999-3004. (Pubitemid 38327724)
31. Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. MiR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 2010;46(3):204-8.
32. Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 2009;48(7):569-82.
33. Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. Let-7 regulates dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008;29(11):2073-7.
34. Jakymiw A, Patel RS, Deming N, Bhattacharyya I, Shah P, Lamont RJ, et al. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 2010;49(6):549-59.
35. Gusev Y. Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA. Methods 2008;44(1):61-72. (Pubitemid 350297987)
36. Varol N, Konac E, Gurocak OS, Sozen S. The realm of microRNAs in cancers. Mol Biol Rep 2010;38(2):1079-89.
37. Selcuklu SD, Donoghue MTA, Spillane C. MiR-21 as a key regulator of oncogenic processes. Biochemical Society Transactions 2009;37:918-25.
38. Li JS, Huang HZ, Sun LJ, Yang M, Pan CB, Chen WL, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009;15(12):3998-4008.
39. Liu X, Wang A, Heidbreder CE, Jiang L, Yu J, Kolokythas A, et al. MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS Lett 2010;584(18):4115-20.
40. Wong TS, Liu XB, Ho ACW, Yuen APW, Ng RWM, Wei WI. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 2008;123(2):251-7. (Pubitemid 351842007)
41. Avissar M, McClean MD, Kelsey KT, Marsit CJ. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009;30(12):2059-63.
42. Jiang Q, Feng MG, Mo YY. Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 2009;9.
43. Jiang L, Liu XQ, Kolokythas A, Yu JS, Wang AX, Heidbreder CE, et al. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 2010;127(3):505-12.
44. Chang KW, Liu CJ, Chu TH, Cheng HW, Hung PS, Hu WY, et al. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 2008;87(11):1063-8.
45. Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, Wu KJ, et al. MiR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 2010;70(4):1635-44.
46. Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y, et al. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol 2010;6(4):e1000730.
47. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol 2009;45(4-5):301-8.
48. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 MicroRNA family. Cell 2005;120(5):635-47. (Pubitemid 40343076)
49. Christensen BC, Moyer BJ, Avissar M, Ouellet LG, Plaza SL, McClean MD, et al. A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers. Carcinogenesis 2009;30(6):1003-7.
50. Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, McClean MD, et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 2010;16(14):3713-20.
51. Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010;23(6):1625-33.
52. Fletcher AM, Heaford AC, Trask DK. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir- 205. Transl Oncol 2008;1(4):202-8.
53. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435(7043):834- 8. (Pubitemid 40839735)
54. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009;174(3):736-45.
55. Gomes CC, Gomez RS. MicroRNA and oral cancer: future perspectives. Oral Oncol 2008;44(10):910-4.
56. Wong TS, Ho WK, Chan JYW, Ng RWM, Wei WI. Mature miR-184 and squamous cell carcinoma of the tongue. The scientific world journal 2009;9:130-2.
57. Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 2010;16(4):360-4.
58. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009;15(17):5473-7.
59. Kota SK, Balasubramanian S. Cancer therapy via modulation of micro RNA levels: a promising future. Drug Discov Today 2010;15(17-18):733-40.
60. Bader AG, Brown D, Winkler M. The promise of microRNA replacement therapy. Cancer Res 2010;70(18):7027-30.
61. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438(7068):685-9.
62. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4(9):721-6. (Pubitemid 47338166)